In Vietnam, a million people are infected with Hepatitis C (HCV). Without treatment, HCV can cause cirrhosis, liver cancer and even death. While no vaccines exist to prevent HCV, the virus is easily treated with directly-acting antivirals (DAAs). In 2017, CHAI worked with the Vietnamese government to pilot a national public sector HCV care and treatment program in order to increase access to DAAs and test real-world outcomes for those initiated on treatment. The initial results were presented at the Global Hepatitis Summit 2018 in Toronto in June.
Preliminary cure rates from the national HCV pilot program in Vietnam
